Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

BACITRACIN 500 UNIT/GM OINTMNT

BACITRACIN
$0.0579per GM
OTC

Strength

500 U/g

Manufacturer

Rugby Laboratories

NDC

00536125628

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

BACITRACIN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M004

On Market Since

4/30/2020

Pharmacological Classes

Decreased Cell Wall Synthesis & Repair

Price History

1W

0.0%

1M

+1.1%

3M

-5.8%

6M

-1.6%

1Y

-7.2%

3Y

-6.2%

5Y

N/A

All

-7.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

BACITRACIN 500 UNIT/GM OINTMNT
Generic
45802006003•Padagis Israel Pharmaceuticals Ltd
$0.0694
per GM
BACITRACIN ZN 500 UNIT/GM OINT
Generic
00536126328•Rugby Laboratories
$0.0732
per GM
BACITRACIN ZN 500 UNIT/GM OINT
Generic
70000054701•Cardinal Health
$0.0732
per GM
BACITRACIN 500 UNIT/GM OINTMNT
Generic
00713028031•Cosette Pharmaceuticals, Inc.
$0.0748
per GM
BACITRACIN 500 UNIT/GM OINTMNT
Generic
68001047747•BluePoint Laboratories
$0.0748
per GM
BACITRACIN ZN 500 UNIT/GM OINT
Generic
36800008902•Topco Associates LLC
$0.0761
per GM
GS FIRST AID ANTIBIOTIC OINT
Generic
00113008464•L. Perrigo Company
$0.0900
per GM
TRIPLE ANTIBIOTIC OINTMENT
Generic
00904880531•Major Pharmaceuticals
$0.0900
per GM
TRIPLE ANTIBIOTIC OINTMENT
Generic
11527016255•Sheffield Pharmaceuticals LLC
$0.0900
per GM
TRIPLE ANTIBIOTIC OINTMENT
Generic
45802014303•Padagis Israel Pharmaceuticals Ltd
$0.0900
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy